Your session is about to expire
← Back to Search
Cool Room Treadmill Training for Multiple Sclerosis
N/A
Waitlist Available
Led By Michelle Ploughman, PhD
Research Sponsored by Memorial University of Newfoundland
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Aged older than 18 and less than 70 years
People with a confirmed diagnosis of relapsing-remitting or progressive MS
Must not have
A relapse of MS
Functional community ambulators (gait speed>120 cm/s)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up following completion of the 12-week exercise intervention and 3-months post-exercise intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial will test how effective a more intense form of exercise is in people with MS who have fatigue and heat-sensitivity.
Who is the study for?
This trial is for people aged 18-70 with a confirmed diagnosis of relapsing-remitting or progressive Multiple Sclerosis. Participants should be stable without MS relapse for at least 90 days and able to walk at least 10 meters, even if they need walking aids.
What is being tested?
The study tests vigorous intensity treadmill training in a cool room (16°C) against low-intensity training to see which is better for restoring functions lost due to MS. The focus is on finding the right amount of exercise that can be tolerated by those who experience fatigue and heat sensitivity from MS.
What are the potential side effects?
Potential side effects may include muscle soreness, fatigue, and temporary worsening of MS symptoms due to physical exertion or reactions to cooler temperatures during the exercise.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 19 and 69 years old.
Select...
I have been diagnosed with relapsing-remitting or progressive MS.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My MS has relapsed.
Select...
I can walk quickly without assistance.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ following completion of the 12-week exercise intervention and 3-months post-exercise intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~following completion of the 12-week exercise intervention and 3-months post-exercise intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Fast walking speed
Secondary study objectives
Fatigue Severity Scale
Hospital Anxiety and Depression Scale
Maximal oxygen consumption during graded exercise test
+7 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Vigorous Intensity GroupExperimental Treatment1 Intervention
More than 60% Heart Rate Reserve
Group II: Low Intensity GroupActive Control1 Intervention
Less than 40% Heart Rate Reserve
Find a Location
Who is running the clinical trial?
Memorial University of NewfoundlandLead Sponsor
70 Previous Clinical Trials
1,835,969 Total Patients Enrolled
2 Trials studying Multiple Sclerosis
62 Patients Enrolled for Multiple Sclerosis
Multiple Sclerosis Society of CanadaOTHER
15 Previous Clinical Trials
977 Total Patients Enrolled
15 Trials studying Multiple Sclerosis
977 Patients Enrolled for Multiple Sclerosis
Michelle Ploughman, PhDPrincipal InvestigatorMemorial University of Newfoundland
1 Previous Clinical Trials
52 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 19 and 69 years old.My MS has relapsed.I have been diagnosed with relapsing-remitting or progressive MS.I can walk at least 10 meters, even if I need help from walking aids.I can walk quickly without assistance.I have been stable with no worsening of my condition for at least 90 days.
Research Study Groups:
This trial has the following groups:- Group 1: Vigorous Intensity Group
- Group 2: Low Intensity Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger